The prototype was part of the overall plan - prototype then production facility. As we know the prototype was completed last December and the following is from the CEO update on the website posted last month.
"The prototype of the synDNA™ production module designed in conjunction with Alpha Laval Biokinetics was completed and tested on schedule. The tests were positive and provided valuable information about quality control measures and performance monitoring. As the Company prepares to initiate operation and validation of the module, we will also implement the next stage of planning for construction of the synDNA™ processing facility.”
I thought I read or heard somewhere a recent possible facility location discussion by the company. I thought the decision was that the facility would be in Houston but not in the current cygx space. Beyond that I don't know if the final site has been selected. I would expect the site selection would probably be in a PR so my assumption is that they haven't figuratively broken ground yet – figuratively because I doubt the this facility would require new building construction - probably just need a reasonable size open space somewhere in the right zoning district. If they use the term “bio-manufacturing” in any site use plans it might raise a few not-in-my-backyard eyebrows of the genetically challenged and cause a delay or require an alternative site selection.
Market Data 
Markets 
AI
